SCHEMBL31031218

SCHEMBL31031218

OC1CN(c2ccn3c(c2)nc2cc(Br)ccc23)C1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SUV39H2 Q9H5I1 2/20 0.34
PIK3CD O00329 2/20 0.33
PIK3CA P42336 2/20 0.33
PIK3CB P42338 2/20 0.33
PIK3CG P48736 2/20 0.33
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
NPC1 O15118 1/20 0.30
TP53 P04637 1/20 0.30
MAPT P10636 1/20 0.30
ALOX15 P16050 1/20 0.30
TSHR P16473 1/20 0.30
MAPK1 P28482 1/20 0.30
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
NPM1 P06748 2/20 0.30
ALK Q9UM73 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31031228 0.87 ALDH1A1 (0.32) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL31031212 0.83 ALDH1A1 (0.39) ALDH1A1KDM4EGLAGAANPC1
SCHEMBL31031232 0.81 KCNH2 (0.34) SUV39H2
SCHEMBL31031233 0.81
SCHEMBL31031251 0.81 SUV39H2 (0.35) SUV39H2
SCHEMBL31031214 0.81 MAPK8 (0.32)
SCHEMBL31031229 0.79 NPC1 (0.30) ALDH1A1NPC1TP53MAPTALOX15
SCHEMBL31031241 0.78 KDM4E (0.37) SUV39H2ALDH1A1KDM4EGLAGAA
SCHEMBL31031257 0.77 ALDH1A1 (0.41) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL18838775 0.77 IKBKB (0.40) SUV39H2ALDH1A1KDM4EGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658651-A1 NOVEL COMPOUNDS FOR TAU IMAGING Eli Lilly and Company (US) 2025-12-10 EP disclosed
WO-2024163546-A1 NOVEL COMPOUNDS FOR TAU IMAGING ELI LILLY AND COMPANY (US) 2024-08-08 WO disclosed